Trial Profile
Cost effectiveness of ezetimibe/simvastatin and rosuvastatin in patients with dyslipidaemias in Mexico
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2012
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 11 Jun 2012 New trial record
- 06 Jun 2012 Results presented at the 17th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.